Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence

Treatment and outcome of IG-MYC⁺ neoplasms with precursor B-cell phenotype in childhood and adolescence

Leukemia. 2020 Mar;34(3):942-946. doi: 10.1038/s41375-019-0606-6. Epub 2019 Oct 14.

¹ Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
² General Pediatrics, University Hospital Muenster, Muenster, Germany.
³ Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
⁴ Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
⁵ Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
⁶ Department of Oncology, Hematology, and Palliative Care, Helios Clinic Bad Saarow, Bad Saarow, Germany.
⁷ Department of Hematology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
⁸ Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
⁹ Department of Human Genetics, Hannover Medical School, Hannover, Germany.
¹⁰ Department of Pathology, University of Giessen, Giessen, Germany.
¹¹ Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Kiel, Germany.
¹² Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
¹³ Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany. birgit.burkhardt@ukmuenster.de.

No abstract available